Form Type: 4

SEC EDGAR Link
Accession Number:0001737287-23-000025
Date:2023-03-14
Issuer: ALLOGENE THERAPEUTICS, INC. (ALLO)
Original Submission Date:

Reporting Person:

CHANG DAVID D
C/O ALLOGENE THERAPEUTICS, INC.
210 EAST GRAND AVENUE SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2023-03-14 F 22,340 d $5.56 2,269,447 direct
COMMON STOCK 2023-03-14 0 $0.00 1,201,108 indirect
COMMON STOCK 2023-03-14 0 $0.00 856,044 indirect
COMMON STOCK 2023-03-14 0 $0.00 856,044 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. this sale is mandated by the issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $5.49 to $5.595, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
f3 includes 135 and 2000 share of the issuer's common stock acquired by the reporting person on september 15, 2021 and on march 15, 2023 pursuant to an employee stock purchase program, respectively.
f4 securities held in the name of the chang 2006 family trust
f5 securities held in the name of the jec 2019 trust dated october 1, 2019.
f6 securities held in the name of the rtc 2019 trust dated october 1, 2019.

Elevate your investments